In an observational study conducted across three pediatric intensive care units (PICUs) in England over a three-month period in 2019, one-sixth of patients experienced at least one adverse drug event, in which they were harmed by a medication.
In the study published in the British Journal of Clinical Pharmacology, 302 patients were included and 62 adverse drug events were confirmed. The estimated incidence of adverse drug events were 20.5 per 100 patients, and most were preventable. Medications for the central nervous system, infections, and the cardiovascular system were commonly implicated with adverse drug events.
“This multicentre study is the first of its kind in the UK hospitals, and its findings can guide future remedial interventions to reduce avoidable medication-related harm in this vulnerable patient population,” said lead author Anwar A. Alghamdi, PhD, of the University of Manchester, in the UK.
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/10.1111/bcp.15150
About Journal
The British Journal of Clinical Pharmacology is a leading international clinical pharmacology journal published by the British Pharmacological Society. It bridges the gap between the medical profession, clinical research and the pharmaceutical industry by addressing all aspects of drug action in humans: invited review articles, original papers and correspondence.
About Wiley
Wiley is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Visit us at Wiley.com, like us on Facebook and follow us on Twitter and LinkedIn.